Apollomics, Inc. (NASDAQ:APLMW – Get Free Report) was the target of a large increase in short interest during the month of May. As of May 29th, there was short interest totaling 24,869 shares, an increase of 60.2% from the May 14th total of 15,523 shares. Based on an average daily trading volume, of 73,878 shares, the short-interest ratio is currently 0.3 days.
Apollomics Stock Performance
APLMW stock opened at $0.01 on Tuesday. The business has a fifty day simple moving average of $0.01 and a 200-day simple moving average of $0.01. Apollomics has a 52 week low of $0.00 and a 52 week high of $0.05.
Apollomics Company Profile
Apollomics, Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and potential commercialization of novel oncology therapies. Since its founding, the company has concentrated on creating targeted and immuno-oncology candidates designed to address unmet needs in solid tumors. Apollomics maintains headquarters in the United States with key research operations in China, leveraging a dual-site strategy to accelerate global development timelines.
The company’s pipeline encompasses a range of therapeutic modalities, including monoclonal antibodies, antibody-drug conjugates and bispecific constructs.
Read More
- Five stocks we like better than Apollomics
- Can D-Wave Hold Its Own Against 2 Fast-Growing Rivals?
- 3 AI Stocks With Moats That Could Outlast Summer Volatility
- These 5 Companies Just Made a Massive Bet on Themselves
- 5 Stocks Built to Thrive in a Higher-for-Longer Economy
Receive News & Ratings for Apollomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollomics and related companies with MarketBeat.com's FREE daily email newsletter.
